Zhejiang Conba Pharmaceutical Co. Ltd. A | Ownership
Companies that own Zhejiang Conba Pharmaceutical Co. Ltd. A
China Universal Asset Management Co., Ltd.
81,600,000
3.26%
81,600,000
0.7%
04/16/2018
E Fund Management Co., Ltd.
25,815,798
1.03%
0
0.18%
03/31/2018
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
14,677,503
0.59%
14,591,804
0.39%
12/31/2017
China Southern Asset Management Co., Ltd.
12,023,075
0.48%
-7,710,003
0.11%
12/31/2017
Harvest Fund Management Co., Ltd.
10,640,418
0.43%
1,050,700
0.07%
07/27/2018
AXA-SPDB Investment Managers Co., Ltd.
8,712,167
0.35%
8,698,722
1.01%
12/31/2017
China Asset Management Co., Ltd.
5,389,488
0.22%
6,700
0.03%
12/31/2017
The Vanguard Group, Inc.
3,535,618
0.14%
0
0%
07/31/2018
Guotai Asset Management Co., Ltd.
3,527,101
0.14%
-2,364,358
0.05%
12/31/2017
Huatai-PineBridge Fund Management Co., Ltd.
3,083,628
0.12%
2,972,474
0.06%
12/31/2017
| Address |
No. 568 Binkang Road
Hangzhou Zhejiang 310052
China
|
|
Employees
|
- |
| Website |
http://www.conbagroup.com |
| Updated |
07/08/2019 |
| Zhejiang Conba Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products. Its manufacturing division consists of modern herbal medicine, chemical drug, and biological drug production. Its products include traditional Chinese medicines, botanical extracts, chemical medicines and raw medicines, and health food. |
